U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 1368

1.
Effective Management of Polycythemia Vera With Ropeginterferon Alfa-2b Treatment
Shan Shan Suo, Rong Feng Fu, Albert Qin, Zong Hong Shao, Jie Bai, Su Ning Chen, Ming Hui Duan, Hu Zhou, Na Xu, Su Jiang Zhang, Xue Lan Zuo, Xin Du, Li Wang, Pei Li, Xu Han Zhang, Dao Xiang Wu, Ya Ning Li, Jing Jing Zhang, Wei Wang, Wei Hong Shen, Oleh Zagrijtschuk, Toshiaki Sato, Zhi Jian Xiao, Jie Jin
J Hematol. 2024 Apr; 13(1-2): 12–22. Published online 2024 Apr 9. doi: 10.14740/jh1245
PMCID:
PMC11027776
ArticlePDF–1.7M
2.
Diagnosis and treatment of polycythemia vera: Brazilian experience from a single institution
Camila da Cruz Gouveia Linardi, Luís Fernando Pracchia, Valeria Buccheri
Sao Paulo Med J. 2008; 126(1): 52–57. Published online 2008 Jan 3. doi: 10.1590/S1516-31802008000100010
PMCID:
PMC11020515
ArticlePDF–380K
3.
Silent Thyroiditis Associated with Ropeginterferon α-2b in a Patient with Polycythemia Vera
Keita Kirito
Intern Med. 2024 Mar 15; 63(6): 843–846. Published online 2023 Aug 2. doi: 10.2169/internalmedicine.2171-23
PMCID:
PMC11008998
ArticlePDF–320K
4.
Updated threshold, renewed problems: should the diagnostic criteria of polycythemia vera be reconsidered? A retrospective cross-sectional cohort study
Anıl Uçan, Müfide Okay Özgeyik
Rev Assoc Med Bras (1992) 2024; 70(1): e20230497. Published online 2024 Mar 15. doi: 10.1590/1806-9282.20230497
PMCID:
PMC10941872
ArticlePDF–391K
5.
In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients
Elena M. Tosca, Alessandro De Carlo, Roberta Bartolucci, Francesco Fiorentini, Silvia Di Tollo, Maurizio Caserini, Maurizio Rocchetti, Paolo Bettica, Paolo Magni
CPT Pharmacometrics Syst Pharmacol. 2024 Mar; 13(3): 359–373. Published online 2024 Feb 7. doi: 10.1002/psp4.13087
PMCID:
PMC10941510
ArticlePDF–8.2M
6.
Late-Onset Hydroxyurea-Induced Melanonychia and Tongue Hyperpigmentation in a Patient With Polycythemia Vera: A Case Report
Nena Letete, Deborah Vaz
Cureus. 2024 Feb; 16(2): e53642. Published online 2024 Feb 5. doi: 10.7759/cureus.53642
PMCID:
PMC10917399
ArticlePDF–2.2M
7.
Ischemic stroke as an initial performance of polycythemia vera in young adults: A case report and literature review
Shuo Hui, Jingru Zhao, Tiantian Huo, Lipeng Dong, Yanzhao Xie, Xinyao Wang, Manli Zhang
Medicine (Baltimore) 2024 Feb 16; 103(7): e36953. Published online 2024 Feb 16. doi: 10.1097/MD.0000000000036953
PMCID:
PMC10869076
ArticlePDF–635K
8.
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology
Marta Garrote, Mónica López-Guerra, Juan Carlos García-Pagán, Eduardo Arellano-Rodrigo, Francisca Ferrer-Marín, Juan Carlos Hernández-Boluda, Beatriz Bellosillo, Meritxell Nomdedeu, Virginia Hernández-Gea, Ana Triguero, Francesca Guijarro, José Álamo, Anna Baiges, Fanny Turon, Dolors Colomer, Francisco Cervantes, Alberto Alvarez-Larrán
Ann Hematol. 2024; 103(3): 737–747. Published online 2024 Jan 24. doi: 10.1007/s00277-023-05610-x
PMCID:
PMC10866782
ArticlePDF–1.1M
9.
Red Blood Cell Contribution to Thrombosis in Polycythemia Vera and Essential Thrombocythemia
Julien M. P. Grenier, Wassim El Nemer, Maria De Grandis
Int J Mol Sci. 2024 Feb; 25(3): 1417. Published online 2024 Jan 24. doi: 10.3390/ijms25031417
PMCID:
PMC10855956
ArticlePDF–1.6M
10.
Common clonal origin of three distinct hematopoietic neoplasms in a single patient: B-cell lymphoma, T-cell lymphoma, and polycythemia vera
Dingani Nkosi, Andrew W. Allbee, Paul G. Rothberg, Jonathan W. Friedberg, Andrew G. Evans
Cold Spring Harb Mol Case Stud. 2023 Dec; 9(4): a006313. doi: 10.1101/mcs.a006313
PMCID:
PMC10815289
ArticlePDF–7.0M
11.
Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report
Silvio Ligia, Emilia Scalzulli, Ida Carmosino, Giovanna Palumbo, Maria Chiara Molinari, Rebecca Poggiali, Alessandro Costa, Maria Laura Bisegna, Maurizio Martelli, Massimo Breccia
Front Oncol. 2023; 13: 1338417. Published online 2024 Jan 9. doi: 10.3389/fonc.2023.1338417
PMCID:
PMC10803620
ArticlePDF–541K
12.
Differences in Clinical Outcomes Between Hydroxyurea-Resistant and -Intolerant Polycythemia Vera Patients
Sung-Eun Lee, Junshik Hong, Soo-Mee Bang, Jinny Park, Chul Won Choi, Sung Hwa Bae, Min Kyoung Kim, Seug Yun Yoon, Sung-Yong Kim
J Korean Med Sci. 2024 Jan 22; 39(3): e24. Published online 2024 Jan 5. doi: 10.3346/jkms.2024.39.e24
PMCID:
PMC10803206
ArticlePDF–1.1M
13.
Obstructive Sleep Apnea Does Not Exclude Polycythemia Vera: A Case Report
Mohammad S. Afana, Mohammad Abu-Tineh, Awni Alshurafa, Khalid Ahmed, Mohammed Abdulgayoom, Mohamed A. Yassin
Case Rep Oncol. 2024 Jan-Dec; 17(1): 91–95. Published online 2024 Jan 11. doi: 10.1159/000535742
PMCID:
PMC10783889
ArticlePDF–221K
14.
Polycythemia Vera: Barriers to and Strategies for Optimal Management
Andrea Duminuco, Patrick Harrington, Claire Harrison, Natalia Curto-Garcia
Blood Lymphat Cancer. 2023; 13: 77–90. Published online 2023 Dec 21. doi: 10.2147/BLCTT.S409443
PMCID:
PMC10749566
ArticlePDF–521K
15.
The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients
Tiziano Barbui, Alessandra Carobbio, Juergen Thiele, Naseema Gangat, Elisa Rumi, Alessandro Rambaldi, Alessandro M. Vannucchi, Ayalew Tefferi, IWG-MRT group
Blood Cancer J. 2023 Dec; 13(1): 187. Published online 2023 Dec 15. doi: 10.1038/s41408-023-00960-1
PMCID:
PMC10724164
ArticlePDF–958K
16.
Change in Polycythemia Vera Treatment: Ropeginterferon Alfa-2b in Light of Current Trials
Heinz Gisslinger
Turk J Haematol. 2023 Dec; 40(4): 266–268. Published online 2023 Dec 5. doi: 10.4274/tjh.galenos.2023.2023.0419
PMCID:
PMC10701315
ArticlePDF–387K
17.
Cost–effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera
Aaron T Gerds, Claudia Castro, Frank Snopek, Megan M Flynn, Alexandra G Ellis, Meredith Manning, Ray Urbanski
J Comp Eff Res. 2023 Sep; 12(9): e230066. Published online 2023 Aug 2. doi: 10.57264/cer-2023-0066
PMCID:
PMC10690394
ArticlePDF–1.1M
18.
Naltrexone: a Novel Approach to Pruritus in Polycythemia Vera
Newsha Nikzad, Leanne Kolnick Jackson
Fed Pract. 2023 Aug; 40(Suppl 3): S73–S75. Published online 2023 Aug 21. doi: 10.12788/fp.0396
PMCID:
PMC10681015
ArticlePDF–751K
19.
Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera
Giulia Benevolo, Monia Marchetti, Remo Melchio, Eloise Beggiato, Chiara Sartori, Carlo Alberto Biolé, Davide Rapezzi, Benedetto Bruno, Alberto Milan
Vasc Health Risk Manag. 2023; 19: 765–778. Published online 2023 Nov 22. doi: 10.2147/VHRM.S429995
PMCID:
PMC10676644
ArticlePDF–2.2M
20.
Iron homeostasis governs erythroid phenotype in polycythemia vera
Cavan Bennett, Victoria E. Jackson, Anne Pettikiriarachchi, Thomas Hayman, Ute Schaeper, Gemma Moir-Meyer, Katherine Fielding, Ricardo Ataide, Danielle Clucas, Andrew Baldi, Alexandra L. Garnham, Connie S. N. Li-Wai-Suen, Stephen J. Loughran, E. Joanna Baxter, Anthony R. Green, Warren S. Alexander, Melanie Bahlo, Kate Burbury, Ashley P. Ng, Sant-Rayn Pasricha
Blood. 2023 Jun 29; 141(26): 3199–3214. Published online 2023 Mar 20. doi: 10.1182/blood.2022016779
PMCID:
PMC10646816
Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center